New to Meducation?
Sign up
Already signed up? Log In

Category

Preview
0
2

Insulin Degludec Distribution to Cease in Germany

As a result of a price dispute, Novo Nordisk is withdrawing Tresibia from Germany. Reactions are mixed.  
medscape.com
about 5 years ago
Preview
0
8

New SonoSite iViz Portable Ultrasound Given Go Ahead in Europe |

SonoSite, now a division of FUJIFILM, just landed CE Mark approval in Europe to introduce its iViz portable ultrasound device. The iViz was developed for u  
medgadget.com
about 5 years ago
Preview
0
0

France's Highest Court Backs Restrictions on BPA Plastics Chemical

France's constitutional court upheld on Thursday restrictions on selling and importing bisphenol A (BPA), a chemical used to stiffen plastics that some studies suggest poses health risks.  
medscape.com
about 5 years ago
Preview
0
0

The role of removing lymph nodes as part of standard surgery for endometrial cancer | Cochrane

The issue Cancer of the lining of the womb (endometrial cancer) is now the most common gynaecological cancer among women in western Europe and North America. Most women (75%) have tumours confined to the body of the womb at the time of diagnosis, and three-quarters of women will survive for 10 years after diagnosis. Lymph node metastases can be found in one in 10 women who appear to have cancer confined to the womb at the time of diagnosis, and removal of all pelvic and para-aortic lymph nodes has been advocated, even for women with presumed early-stage cancer. This recommendation is based on non-randomised studies that suggested improvement in survival following removal of pelvic and para-aortic lymph nodes. However, treatment of pelvic lymph nodes may not be beneficial, and additional treatment to lymph nodes might not necessarily be better treatment, especially as surgical removal of lymph nodes has serious potential short-term and long-term harmful effects.  
cochrane.org
about 5 years ago
Preview
0
2

St. Jude's Infinity Deep Brain Stimulation System Gets Nod in Europe |

St. Jude Medical received European CE Mark approval to introduce its Infinity deep brain stimulation (DBS) implant and matching directional DBS lead for pe  
medgadget.com
about 5 years ago
Preview
0
0

WHO says most people in Europe too fat - BBC News

Most people in Europe are too fat, according to a report by the World Health Organization (WHO).  
bbc.co.uk
about 5 years ago
Preview
0
0

Europeans are “world champions” at drinking and smoking

Levels of alcohol consumption, tobacco use, overweight, and obesity are still “alarmingly high” in Europe, a World Health Organization report has found.  
feeds.bmj.com
about 5 years ago
Preview
0
0

'Distressing' Differences in Survival Across Europe

Rates of 5-year cancer survival in Europe may have increased in recent years, but marked regional variations remain, data on more than 10 million patients indicate.  
medscape.com
about 5 years ago
Preview
0
2

Parkinson's Combo Drug (Numient) Gets Go Ahead in Europe

The Committee for Medicinal Products for Human Use recommends marketing authorization for IPX066 (Numient), a modified-release oral capsule formulation of levodopa-carbidopa for Parkinson's.  
medscape.com
about 5 years ago
Preview
0
0

Comparison of hospital variation in acute myocardial infarction care and outcome between Sweden and United Kingdom: population based cohort study using nationwide clinical registries

Objective To assess the between hospital variation in use of guideline recommended treatments and clinical outcomes for acute myocardial infarction in Sweden and the United Kingdom.  
feeds.bmj.com
about 5 years ago
Preview
2
29

Comparison of hospital variation in acute myocardial infarction care and outcome between Sweden and United Kingdom

Objective To assess the between hospital variation in use of guideline recommended treatments and clinical outcomes for acute myocardial infarction in Sweden and the United Kingdom.  
feeds.bmj.com
about 5 years ago
Preview
0
4

Neuravi EmboTrap Clot Retrieval Device for Stroke Cleared in Europe |

Neuravi, a company out of Galway, Ireland, is releasing a new clot retrieval device for treating ischemic strokes. The minimally invasive EmboTrap is pushe  
medgadget.com
about 5 years ago
Preview
0
0

Ambitious Plan to Improve Childhood Cancer Care in Europe

An ambitious plan to tackle disparities in the provision of pediatric oncology care and access to treatment across Europe has been launched by a group of experts.  
medscape.com
about 5 years ago
Preview
0
0

Occlutech Muscular Ventricle Septal Defect Closure Device Going on Sale in Europe |

Occlutech, a firm out of Helsingborg, Sweden, is releasing in Europe the new muscular Ventricle Septal Defect Closure Device (mVSD). Used in a minimally in  
medgadget.com
about 5 years ago
Preview
0
0

Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database

Population Deaths from colorectal cancer between 1970 and 2011. Profound changes in screening and treatment efficiency took place after 1988; therefore, particular attention was paid to the evolution of colorectal cancer mortality in the subsequent period.  
feeds.bmj.com
about 5 years ago
Preview
0
11

Colorectal Cancer Screening: Overview of Existing Programs

How is colorectal cancer screened in Asia, Africa, Europe, and the Americas? Learn about screening methods used around the world.  
medscape.com
about 5 years ago
Preview
0
0

Council of Europe tackles drug industry’s “less noble” side

Parliamentarians from 47 European countries have overwhelmingly given their backing to moves for more openness in drug companies’ relationships with the health sector. In particular, they want the companies to make all links with the sector publicly available and to disclose the real costs of researching and developing new medicines.  
feeds.bmj.com
about 5 years ago
Preview
0
0

Council of Europe tackles drug industry’s “less noble” side

Parliamentarians from 47 European countries have overwhelmingly given their backing to moves for more openness in drug companies’ relationships with the health sector. In particular, they want the companies to make all links with the sector publicly available and to disclose the real costs of researching and developing new medicines.  
feeds.bmj.com
about 5 years ago